Related Experiment Video
Updated: Dec 24, 2025
10:13
Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
12.5K
A versatile bacterial membrane-binding chimeric peptide with enhanced photodynamic antimicrobial activity.
Ai-Nv Zhang1, Wei Wu, Chi Zhang
1College of Pharmacy, Hubei University of Medicine, Shiyan 442000, P. R. China.
Journal of Materials Chemistry. B
|April 8, 2020
Summary
A novel chimeric peptide, PPK, combines a photosensitizer with an antimicrobial peptide to effectively kill bacteria using photodynamic therapy. This approach shows promise for combating antibiotic resistance and treating infections with minimal side effects.
Area of Science:
- Biotechnology
- Antimicrobial Research
- Photodynamic Therapy
Background:
- Antibiotic resistance poses a significant global health threat.
- Photodynamic therapy (PDT) offers an alternative strategy to combat resistant bacteria.
- Developing novel antimicrobial agents is crucial for effective infection control.
Purpose of the Study:
- To engineer a versatile bacterial membrane-binding chimeric peptide for enhanced photodynamic inactivation of bacteria.
- To investigate the mechanism of action of the chimeric peptide PPK.
- To evaluate the in vitro and in vivo efficacy of PPK against bacterial infections.
Main Methods:
- Conjugation of protoporphyrin IX (PpIX) with a chimeric antimicrobial peptide (KLAKLAK)2 (KLA) to form PPK.
- Characterization of PPK's properties, including charge and conformation.
- Assessment of PPK's binding affinity to bacterial membranes via electrostatic interactions and membrane insertion.
- Evaluation of PPK's antimicrobial activity against Staphylococcus aureus and Escherichia coli in vitro.
- Testing PPK's therapeutic efficacy in a mouse model of Staphylococcus aureus infection.
Main Results:
- The chimeric peptide PPK demonstrated rapid binding to microbial cells and disruption of bacterial membranes.
- PPK effectively generated reactive oxygen species (ROS) under 660 nm light, leading to bacterial inactivation.
- In vitro studies confirmed PPK's potent antimicrobial activity against both Gram-positive S. aureus and Gram-negative E. coli.
- In vivo experiments showed excellent therapeutic effects in S. aureus-infected mice with no observed systemic side effects.
Conclusions:
- The developed chimeric peptide PPK is a promising agent for photodynamic antibiosis.
- PPK's dual action of membrane disruption and ROS generation offers an effective strategy against bacterial infections.
- This novel approach holds significant potential for overcoming antibiotic resistance and developing new therapeutic interventions.
